Anaemia in inflammatory bowel disease: A population-based 10-year follow-up

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 1, 2014, Pages 69-76

  Hoivik M L ^a,b   Reinisch, W ^c   Cvancarova, M ^a,d   Moum, B ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; HEMOGLOBIN;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGE; AGED; ANEMIA; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL EXAMINATION; COHORT ANALYSIS; COLON RESECTION; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORWAY; NORWEGIAN; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SCHOOL CHILD; SMOKING; ULCERATIVE COLITIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 84889651633     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12541     Document Type: Article

References (27)

1. Kulnigg S, Gasche C,. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006; 24: 1507-23.
2. Pizzi LT, Weston CM, Goldfarb NI, et al,. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 47-52.
3. Wells CW, Lewis S, Barton JR, Corbett S,. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006; 12: 123-30.
4. Reinisch W, Staun M, Bhandari S, Munoz M,. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J Crohns Colitis 2013; 7: 429-40.
5. Gomollon F, Gisbert JP,. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009; 15: 4659-65.
6. Gasche C, Lomer MC, Cavill I, Weiss G,. Iron, anaemia, and inflammatory bowel diseases. Gut 2004; 53: 1190-7.
7. Gisbert JP, Gomollon F,. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008; 103: 1299-307.
8. Gasche C,. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis 2000; 6: 142-50.
9. Wilson A, Reyes E, Ofman J,. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004; 116: Suppl.-49S.
10. Bager P, Befrits R, Wikman O, et al,. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol 2011; 46: 304-9.
11. Rejler M, Tholstrup J, Andersson-Gare B, Spangeus A,. Low prevalence of anemia in inflammatory bowel disease: a population-based study in Sweden. Scand J Gastroenterol 2012; 47: 937-42.
12. Moum B, Vatn MH, Ekbom A, et al,. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996; 31: 362-6.
13. Moum B, Ekbom A, Vatn MH, et al,. Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut 1997; 40: 328-32.
14. Henriksen M, Jahnsen J, Lygren I, et al,. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis 2006; 12: 543-50.
15. Solberg IC, Lygren I, Jahnsen J, et al,. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009; 44: 431-40.
16. World Health Organization. Iron Deficiency Anemia Assessment, Prevention and Control A guide for programme managers. Report; 2011. Report No.: WHO/NHP/01.3.
17. Gasche C, Scholmerich J, Brynskov J, et al,. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15.
18. Skjelbakken T, Langbakk B, Dahl IM, Lochen ML, Tromso S,. Haemoglobin and anaemia in a gender perspective: the Tromso Study. Eur J Haematol 2005; 74: 381-8.
19. Altman DG, Machin D, Bryant T, et al,. Statistics with confidence. 2nd ed. London: Wiley, 2000.
20. Solberg IC, Vatn MH, Hoie O, et al,. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007; 5: 1430-8.
21. Van Assche G, Dignass A, Reinisch W, et al,. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis 2010; 4: 63-101.
22. Blumenstein I, Herrmann E, Filmann N, et al,. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. J Crohns Colitis 2011; 5: 203-10.
23. Høivik ML, Bernklev T, Solberg IC, et al,. Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: Ten-year results from the IBSEN study. J Crohns Colitis 2012; 6: 441-53.
24. Høivik ML, Moum B, Solberg IC, et al,. Work disability in inflammatory bowel disease patients 10 â€..years after disease onset: results from the IBSEN Study. Gut 2013; 62: 368-75.
25. Weiss G, Gasche C,. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica 2010; 95: 175-8.
26. Leifert JA,. Anaemia and cigarette smoking. Int J Lab Hematol 2008; 30: 177-84.
27. Reinisch W, Chowers Y, Danese S, et al,. The management of iron deficiency in inflammatory bowel disease-an online tool developed by the RAND/UCLA appropriateness method. Aliment Pharmacol Ther 2013; 38: 1109-18.